StonvexLoading…
StonvexStonvexStonvexCore line items from SMHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $227.83M | $271.36M | $279.51M | $217.32M |
Operating Income | $13.72M | $-10.43M | $35.52M | $-54.00M |
Net Income | $-27.84M | $-78.12M | $-9.31M | $-71.65M |
EPS (Diluted) | $-1.06 | $-2.82 | $-0.34 | $-2.69 |
Total Assets | $660.60M | $727.11M | $780.34M | $815.37M |
Total Liabilities | $395.93M | $428.79M | $406.11M | $436.22M |
Cash & Equivalents | $68.93M | $59.49M | $67.45M | $39.96M |
Free Cash Flow OCF − CapEx | $-85.18M | $-17.56M | $-1.66M | $-15.08M |
Shares Outstanding | 26.22M | 27.66M | 27.08M | 26.63M |